英文名称 | CAS号 | 中文名 | 中文别名 | 分子式 | 分子量 | EINECS号 |
---|---|---|---|---|---|---|
BIBF 1202
|
894783-71-2 |
BIBF 122
|
CS-1313;NINTEDANIB杂质6;NINTEDANIB-1;尼达尼布杂质BIBF 1202;英丹尼布杂质A;尼替丹尼羧酸;尼达尼布杂质6(依替泰尼杂质6);尼达尼布杂质6
|
C30H31N5O4 |
525.59824 | |
5-Carboxytetramethylrhodamine
|
91809-66-4 |
5-羧基四甲基罗丹明
|
CS-1311;5-羧基四甲基罗丹明;5-羧基四甲基罗丹明(单一化合物);5-羧基四甲基罗丹明(开环);5-TAMRA [5-羧基四甲基罗丹明]
|
C25H22N2O5 |
430.45 | |
6-Carboxytetramethylrhodamine
|
91809-67-5 |
6-羧基四甲基罗丹明
|
CS-1310;6-羧基四甲基罗丹明;6-羧基四甲基若丹明;6-羧基四甲基罗丹明(单一化合物);6-羧基四甲基罗丹明 FOR FLUORESCENCE;6-TAMRA [6-羧基四甲基罗丹明];6-羧基四甲基罗丹明,FOR FLUORESCENCE,≥90%
|
C25H22N2O5 |
430.45 | |
Uprosertib
|
1047634-65-0 |
UPROSERTIB
|
GSK2141795;GSK2141795 (Uprosertib, GSK795);Uprosertib;Uprosertib(GSK2141795);Uprosertib , GSK2141795C;GSK 2141795C;Uprosertib (GSK-2141795,GSK795);N-[(1S)-2-Amino-1-[(3,4-difluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-furancarboxamide
|
C18H16Cl2F2N4O2 |
||
N6-methyladenosine
|
1867-73-8 |
N6-甲基腺苷
|
CS-1297;N6-甲基腺苷盐酸盐;N6-甲基腺苷 1G;N6-甲基腺苷一水合物
|
C11H15N5O5 |
297.2673 | 200-001-2 |
YH239-EE
|
1364488-67-4 |
YH239-EE
|
|
C25H27Cl2N3O4 |
504.42 | |
(R)-1,2,6,7,8,9-Hexahydro-1,6,6-trimethyl-phenanthro(1,2-b)furan-10,11-dione
|
35825-57-1 |
隐丹参酮
|
隐丹参酮;(R)-1,6,6-三甲基-1,2,7,8,9-六氢-菲并[1,2-B]呋喃-10,11-二酮;隐丹参醌;隐丹参酮(标准品);隐丹参酮,来源于丹参;隐丹参酮(隐丹参醌);CRYPTOTANSHINONE 隐丹参酮
|
C19H20O3 |
296.36 | |
ATB 346
|
1226895-20-0 |
ATB 346
|
ATB346;ATB 346;ABT-346 抑制剂;CS-1282;4-CARBAMOTHIOYLPHENYL 2-(6-METHOXYNAPHTHALEN-2-YL)PROPANOATE
|
C21H19NO3S |
365.44546 | |
Kobe2602
|
454453-49-7 |
KOBE-262
|
2-[2,6-二硝基-4-(三氟甲基)苯基]-N-(4-氟苯基)肼基硫代甲酰胺
|
C14H9F4N5O4S |
419.310973 | |
GNE-7915
|
1351761-44-8 |
GNE7915
|
GNE7915;GNE 7915;CS-1279
|
C19H21F4N5O3 |
443.395353 | |
GNE0877
|
1374828-69-9 |
GNE-877
|
ALPHA,3-三甲基-4-[[4-(甲基氨基)-5-(三氟甲基)-2-嘧啶基]氨基]-1H-吡唑-1-乙腈;GNE-0877;GNE 0877;GNE0877.;CS-1275
|
C14H16F3N7 |
339.3189496 | -0 |
Mirodenafil di hydrochloride
|
862189-96-6 |
米罗那非二盐酸盐
|
米罗那非二盐酸盐;CS-1262
|
C26H39Cl2N5O5S |
531.66748 | |
AT13148
|
1056901-62-2 |
AT13148
|
AT-13148;AT 13148;(+)-(S)-2-氨基-1-(4-氯苯基)-1-[4-(1H-吡唑-4-基)苯基]乙醇;CS-1252
|
C17H16ClN3O |
313.78144 | |
NMS-1286937
|
1034616-18-6 |
NMS-P937 (NMS1286937)
|
4,5-二氢-1-(2-羟基乙基)-8-[[5-(4-甲基-1-哌嗪基)-2-(三氟甲氧基)苯基]氨基]-1H-吡唑并[4,3-H]喹唑啉-3-甲酰胺;CS-1243
|
C24H27F3N8O3 |
532.51819 | |
UM729
|
1448723-60-1 |
UM729
|
UM729;C07;methyl 4-(3-(piperidin-1-yl)propylamino)-9H-pyrimido[4,5-b]indole-7-carboxylate;4-[[3-(1-Piperidinyl)propyl]amino]-9H-pyrimido[4,5-b]indole-7-carboxylic acid methyl ester
|
|||
EHT 1864
|
754240-09-0 |
EHT 1864
|
EHT-1864;EHT-1864;CS-1343;CS-1239
|
C25H27F3N2O4S2HCl |
581.47496 | |
KX1-004
|
518058-84-9 |
KX1-4
|
CS-1235;5-氟-N-[(3-羟基苯基)甲基]-1H-吲哚-2-甲酰胺
|
C16H13FN2O2 |
284.285023 | |
THZ1
|
1604810-83-4 |
THZ1
|
CDK7 inhibitor;THZ1;THZ1, CDK7 inhibitor;THZ1 ?N-{4-[5-Chloro-4-(1H-indol-3-yl)-pyrimidin-2-ylamino]-phenyl}-4-(4-dimethylamino-but-2-enoylamino)-benzamide;(E)-N-(3-((5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)-4-(4-(dimethylamino)but-2-enamido)benzamide THZ1;N-[3-[[5-Chloro-4-(1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-4-[[(2E)-4-(dimethylamino)-1-oxo-2-buten-1-yl]amino]benzamide;THZ1 free base;(E)-N-(3-((5-Chloro-4-(1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)-4-(4-(dimethylamino)but-2-en
|
|||
Roquinimex
|
84088-42-6 |
罗喹美克
|
罗喹美克;1,2-二氢-4-羟基-N,N-二甲基-2-氧代-N-苯基-3-喹啉甲酰胺;CS-1232;利诺安
|
C18H16N2O3 |
308.33 | |
4E1RCat
|
328998-25-0 |
4E1RCAT
|
4-[2,3-二氢-3-[[5-(4-硝基苯基)-2-呋喃基]亚甲基]-2-氧代-5-苯基-1H-吡咯-1-基]苯甲酸;CS-1228
|
C28H18N2O6 |
478.45232 |